|  Help  |  About  |  Contact Us

Publication : SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease.

First Author  Hong Y Year  2012
Journal  J Neurosci Volume  32
Issue  48 Pages  17262-72
PubMed ID  23197718 Mgi Jnum  J:193052
Mgi Id  MGI:5467465 Doi  10.1523/JNEUROSCI.3300-12.2012
Citation  Hong Y, et al. (2012) SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease. J Neurosci 32(48):17262-72
abstractText  Serine-arginine protein kinases 2 (SRPK2) is a cell cycle-regulated kinase that phosphorylates serine/arginine domain-containing proteins and mediates pre-mRNA splicing with unclear function in neurons. Here, we show that SRPK2 phosphorylates tau on S214, suppresses tau-dependent microtubule polymerization, and inhibits axonal elongation in neurons. Depletion of SRPK2 in dentate gyrus inhibits tau phosphorylation in APP/PS1 mouse and alleviates the impaired cognitive behaviors. The defective LTP in APP/PS1 mice is also improved after SRPK2 depletion. Moreover, active SRPK2 is increased in the cortex of APP/PS1 mice and the pathological structures of human Alzheimer's disease (AD) brain. Therefore, our study suggests SRPK2 may contribute to the formation of hyperphosphorylated tau and the pathogenesis of AD.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression